Literature DB >> 32191143

Should patients stop their biologic treatment during the COVID-19 pandemic.

Arjun M Bashyam1, Steven R Feldman1,2,3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32191143     DOI： 10.1080/09546634.2020.1742438

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN： 0954-6634            Impact factor:   3.359


× No keyword cloud information.
  27 in total

1.  Impact of the COVID-19 Pandemic on Immunomodulatory and Immunosuppressive Therapies in Dermatology: Patient and Physician Attitudes in Argentina.

Authors:  S Zimman; M J Cura; P C Lun; C M Echeverría; L D Mazzuoccol
Journal:  Actas Dermosifiliogr       Date:  2020-10-17

Review 2.  Dermatologists and SARS-CoV-2: the impact of the pandemic on daily practice.

Authors:  P Gisondi; S Piaserico; A Conti; L Naldi
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-06       Impact factor: 9.228

3.  Management of patients with hidradenitis suppurativa during the COVID-19 pandemic.

Authors:  Trinidad Montero-Vilchez; Antonio Martinez-Lopez; Luis Salvador-Rodriguez; Alejandro Molina-Leyva; Salvador Arias-Santiago
Journal:  Dermatol Ther       Date:  2020-07-07       Impact factor: 3.858

Review 4.  Patients with specific skin disorders who are affected by COVID-19: What do experiences say about management strategies? A systematic review.

Authors:  Niloufar Najar Nobari; Azadeh Goodarzi
Journal:  Dermatol Ther       Date:  2020-07-07       Impact factor: 3.858

5.  COVID-19 patients with psoriasis and psoriatic arthritis on biologic immunosuppressant therapy vs apremilast in North Spain.

Authors:  Rubén Queiro Silva; Susana Armesto; Carmen González Vela; Cristina Naharro Fernández; Miguel Angel González-Gay
Journal:  Dermatol Ther       Date:  2020-07-27       Impact factor: 3.858

Review 6.  Challenges of COVID-19 pandemic for dermatology.

Authors:  Uwe Wollina
Journal:  Dermatol Ther       Date:  2020-04-30       Impact factor: 3.858

7.  The impact of the COVID-19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience.

Authors:  P Gisondi; P Facheris; P Dapavo; S Piaserico; A Conti; L Naldi; S Cazzaniga; P Malagoli; A Costanzo
Journal:  Br J Dermatol       Date:  2020-05-28       Impact factor: 11.113

Review 8.  Complexities of diagnosis and management of COVID-19 in autoimmune diseases: Potential benefits and detriments of immunosuppression.

Authors:  Tsvetoslav Georgiev; Alexander Krasimirov Angelov
Journal:  World J Clin Cases       Date:  2020-09-06       Impact factor: 1.337

9.  Cutaneous manifestations and considerations in COVID-19 pandemic: A systematic review.

Authors:  Farnoosh Seirafianpour; Sogand Sodagar; Arash Pour Mohammad; Parsa Panahi; Samaneh Mozafarpoor; Simin Almasi; Azadeh Goodarzi
Journal:  Dermatol Ther       Date:  2020-08-06       Impact factor: 3.858

10.  Biologic agents in psoriasis: our experience during coronavirus infection.

Authors:  Davide Strippoli; Tania Barbagallo; Francesca Prestinari; Giuseppe Russo; Fabrizio Fantini
Journal:  Int J Dermatol       Date:  2020-06-09       Impact factor: 3.204
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.